CFO Joel Grade told investors Friday that Baxter expects an approximately $200 million hit to sales in the fourth quarter ...

Donald Trump’s election victory comes weeks after the FDA named a new leader for the medical device center and as the ...

Insulet saw strong insulin pump adoption among new users with Type 2 diabetes following its recent FDA clearance, while ...

CEO Eric Lefkofsky said the purchase of Ambry Genetics will expand Tempus’ testing portfolio and bring in a fast-growing ...

Poul will take over the company in January after spending 11 years with 3M and working at Medtronic and Boston Scientific.

CEO Bernd Montag said the company is well positioned for a “U.S. versus China situation” that could arise when Donald Trump ...

The three medtech firms unveiled new data this week during TCT 2024 in Washington, D.C. Here’s what the results mean for the ...

Cortex adds to Boston Scientific’s electrophysiology portfolio amid treatment shifts in the space driven by new pulsed field ...

Patient advocates are hoping for change under new director Michelle Tarver, while industry groups look to build on former ...

Executives said the patient monitoring company’s consumer business will likely become a discontinued operation if it is not ...

Study author Philippe Genereux said the trial data “shatter 60 years of ingrained belief on the treatment for severe aortic ...

The document clarifies that EtO falls within the scope of the Medical Device Regulation and the In Vitro Diagnostic ...